InMed Pharmaceuticals Inc. (INM) Financial Statements (2024 and earlier)

Company Profile

Business Address SUITE 310, 815 W. HASTINGS STREET
VANCOUVER, BC V6C 1B4
State of Incorp. BC
Fiscal Year End June 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
MRQ
6/30/2023
6/30/2022
6/30/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9,5008,9576,2227,410
Cash and cash equivalents9,5358,9136,1777,363
Short-term investments44444546
Other undisclosed cash, cash equivalents, and short-term investments(79)   
Receivables3732608812
Inventory, net of allowances, customer advances and progress billings, including:745942,491 
Inventory7451,6162,491 
Other undisclosed inventory, net of allowances, customer advances and progress billings  (1,523)  
Deferred costs    112
Other undisclosed current assets1,1922,021797845
Total current assets:11,81011,3329,5988,378
Noncurrent Assets
Property, plant and equipment1,481723 327
Intangible assets, net (including goodwill)1,8641,9462,1091,062
Intangible assets, net (excluding goodwill)1,8641,9462,1091,062
Other noncurrent assets10010517715
Other undisclosed noncurrent assets   904 
Total noncurrent assets:3,4452,7753,1901,403
TOTAL ASSETS:15,25514,10612,7889,781
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,2881,6092,4152,135
Accounts payable306544  
Accrued liabilities100542  
Other undisclosed accounts payable and accrued liabilities8815222,4152,135
Deferred rent credit 2916  
Other undisclosed current liabilities36437690480
Total current liabilities:1,6802,0013,3202,215
Noncurrent Liabilities
Long-term debt and lease obligation:   389189
Liabilities, other than long-term debt80316  
Operating lease, liability80316389189
Other undisclosed noncurrent liabilities   (389)(189)
Total noncurrent liabilities:80316389189
Total liabilities:2,4832,0173,7092,405
Equity
Equity, attributable to parent12,77212,0909,0797,377
Common stock79,93777,62070,71860,587
Additional paid in capital38,12235,74131,68421,513
Accumulated other comprehensive income129129129129
Accumulated deficit(105,415)(101,400)(93,453)(74,852)
Total equity:12,77212,0909,0797,377
TOTAL LIABILITIES AND EQUITY:15,25514,10612,7889,781

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
TTM
6/30/2023
6/30/2022
6/30/2021
Revenues5,4874,1361,089 
Cost of revenue(3,383)(2,424)(546) 
Cost of goods and services sold(1,265)(309)(546) 
Other undisclosed gross profit4(309)  
Gross profit:2,1081,403544 
Operating expenses(9,092)(9,782)(17,808)(9,938)
Other undisclosed operating loss   (1,336) 
Operating loss:(6,983)(8,379)(18,600)(9,938)
Nonoperating expense(42)(48)(21)(265)
Investment income, nonoperating322 96259
Loss, foreign currency transaction, before tax(51)(48)(118)(163)
Other nonoperating expense    (360)
Loss from continuing operations before equity method investments, income taxes:(7,025)(8,427)(18,622)(10,203)
Other undisclosed income from continuing operations before income taxes677492  
Loss from continuing operations before income taxes:(6,348)(7,935)(18,622)(10,203)
Income tax expense  (13)  
Other undisclosed loss from continuing operations(13)   
Loss from continuing operations:(6,361)(7,948)(18,622)(10,203)
Loss before gain (loss) on sale of properties:(18,622)(10,203)
Other undisclosed net income65015,84837,22220,403
Net income (loss):(5,711)7,90018,60010,200
Other undisclosed net loss attributable to parent(640)(15,848)(37,200)(20,403)
Net loss available to common stockholders, diluted:(6,351)(7,948)(18,600)(10,203)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
TTM
6/30/2023
6/30/2022
6/30/2021
Net income (loss):(5,711)7,90018,60010,200
Comprehensive income (loss):(5,711)7,90018,60010,200
Other undisclosed comprehensive income (loss), net of tax, attributable to parent15,208 (37,200)(19,973)
Comprehensive income (loss), net of tax, attributable to parent:9,4967,900(18,600)(9,773)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: